Ricardo M. Camelo, MD, MSc, MBA

Physician
Faculty of Pharmacy, Universidade Federal de Minas Gerais
Belo Horizonte, Minas Gerais, Brazil

Ricardo Mesquita Camelo, Brazilian Physician and Researcher on Rare Bleeding Disorders.
Hemophilia (hereditary and acquired), FXIII deficiency, and Glanzmann thrombasthenia
Current PhD student at two institutions: Faculty of Medicine, Universidade Federal de Minas Gerais, Brazil, and Clinical Epidemiology, Leiden University Medical Centre, the Netherlands.
Master in Physiology and Pharmacology, Universidade Federal de Minas Gerais.
Contacts: +55.31.99151.8362 and rmcamelo@hotmail.com

Presentation(s):

• PB0689 - Efficacy/effectiveness of extended half-life factor VIII concentrates on the prophylaxis of people with hemophilia A: A systematic review and meta-analysis

  Monday, June 26, 2023
  18:30 – 19:30 ET

• OC 50.1 - Levels of IgG4 distinguish immune tolerance induction outcome in patients with inherited hemophilia A: results from the BrazIT Study

  Tuesday, June 27, 2023
  10:45 – 11:00 ET

• PB1321 - Efficacy/Effectiveness and Safety of Emicizumab Prophylaxis in the Treatment of Hemophilia A: A Systematic Review with Meta-Analysis

  Tuesday, June 27, 2023
  18:30 – 19:30 ET

• PB1322 - Emicizumab wastage estimation for treating people with hemophilia A and inhibitors who failed immune tolerance induction according to the current Brazilian public health protocol

  Tuesday, June 27, 2023
  18:30 – 19:30 ET